Heron Therapeutics

Heron Therapeutics, Inc. (formerly AP Pharma, Inc.) is a specialty pharmaceutical company developing products using its proprietary Biochronomer™ polymer drug delivery platform. The company's lead product candidate, APF530, is being developed for the prevention of acute chemotherapy-induced nausea and vomiting (CINV) in patients.